| Active Market | Forge Price1 | Last Funding Round | Trade Eligibility | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Company | Sector & Subsector | Market Activity4   |
Highest Bid | Lowest Ask | Last Matched | +/- to LFR | $ Total Bids | $ Total Asks | # Bids | # Asks | Current Price |
6-month |
1-year |
Total Funding |
Round | Date | Amount Raised |
Post-Money Valuation3 |
Price |
Key Investors | Common | Preferred | Fund | ||
 | HeartFlow | Healthcare Healthcare Providers & Services | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $755.52MM | Series F | 4/6/2023 | $174.86MM | $546.5MM | $2.85 | Bain Capital, Janus Henderson Investors, Baillie Gifford, Capricorn Investment Group, Hayfin Capital Management, HealthCor, Martis Capital, USVP, Wellington Management | ||||
 | The Athletic | Consumer & Lifestyle Media | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $171.17MM | Series D | 1/20/2020 | $75MM | $546.12MM | $8.65 | Bedrock Capital, Emerson Collective, Powerhouse Capital, Y Combinator, Plus Capital | ||||
 | Articul8 AI | Enterprise Software Productivity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $75MM | Series B-1 | 1/7/2026 | $23.29MM | $546.1MM | $19.46 | Adara Ventures, Aditya Birla Ventures, NXC, Dragon Global | ||||
 | Tecovas | Consumer & Lifestyle Clothing, Fashion, Beauty & Apparel | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $106.69MM | Series C-1 | 6/17/2025 | $10MM | $545.36MM | $18.00 | Undisclosed Investors | ||||
 | Securitize | Fintech Blockchain | Medium | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $106.76MM | Series B-4 | 5/1/2024 | $29.2MM | $544.4MM | $21.60 | BlackRock, Hamilton Lane, ParaFi Capital, Tradeweb Markets, Aptos Labs, Circle, Paxos | ||||
 | Replicant | Enterprise Software Business Operations | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $115.07MM | Series B-1 | 4/26/2022 | $80MM | $544.38MM | $1.08 | Stripes, Salesforce Ventures, IronGrey, Omega Venture Partners, Norwest Venture Partners, Atomic | ||||
 | Neurelis | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $247.94MM | Series D | 3/9/2021 | $114.76MM | $544.18MM | $3.15 | Cormorant Asset Management, Decheng Capital, LYZZ Capital, HBM Healthcare Investments, Philos & Partners SA | ||||
 | Descript | Consumer & Lifestyle Media | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $102.62MM | Series C | 11/15/2022 | $50.7MM | $543.78MM | $15.31 | OpenAI, Andreessen Horowitz, Redpoint Ventures, Spark Capital, Daniel Gross | ||||
 | Knewton | Education E-Learning | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $138.99MM | Series F | 2/2/2016 | $59.01MM | $542.87MM | $13.97 | Accel, Atomico, Bessemer Venture Partners, EDBI, FirstMark Capital, First Round Capital, and Foudners Fund | ||||
 | Precision Neuroscience | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $182.65MM | Series C | 12/16/2024 | $102MM | $542.69MM | $5.70 | General Equity Holdings, B Capital, Duquesne Family Office, Steadview Capital | ||||
 | Farther | Fintech Personal Finance | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $126.22MM | Series C | 10/10/2024 | $72.33MM | $542.36MM | $7.00 | CapitalG, Viewpoint Ventures | ||||
 | Viridi | Energy Energy Storage | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $189.58MM | Series E | 2/2/2026 | $20MM | $541.61MM | $7.26 | Undisclosed Investors | ||||
 | Prepared | Enterprise Software Other Enterprise Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $137.22MM | Series C-1 | 5/30/2025 | $71.47MM | $541.38MM | $11.98 | General Catalyst, Andreessen Horowitz, First Round Capital, Radical Ventures | ||||
 | Truepill | Healthcare Digital Health | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $929.28MM | Series E-1 | 8/16/2023 | $7.49MM | $541.17MM | $22.68 | Undisclosed Investors | ||||
 | Amylyx | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $203.25MM | Series C-1 | 7/20/2021 | $107.33MM | $541.01MM | $10.27 | Viking Global Investors, Bain Capital Life Sciences, Perceptive Advisors, Rock Springs Capital, Woodline Partners, Marshall Wace, Tybourne Capital Management, Verition Fund Management, aMoon Fund, Falcon Edge, Morningside Ventures, 683 Capital Management, Belinda Termeer, Polaris Founders Capital | ||||
 | Interos | Industrial Industrial Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $357.76MM | Series D | 1/5/2026 | $65.56MM | $540.97MM | $100.00 | Blue Owl Capital, Structural Capital | ||||
 | Pacaso | Real Estate Real Estate Software | Low | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $235.78MM | Series C-3 | 7/31/2025 | $13.41MM | $540.92MM | $1.76 | Undisclosed Investors | ||||
 | LendUp | Fintech Lending | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $124.37MM | Series C | 7/1/2016 | $47.5MM | $540.86MM | $2.66 | Paypal, Y Combinator | ||||
 | Cobot | Industrial Robotics | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $141.62MM | Series B | 4/10/2024 | $100MM | $540.52MM | $34.85 | General Catalyst, Bison Ventures, Industry Ventures, Lux Capital, Sequoia Capital, Khosla Ventures, Mayo Clinic, Neo, 1984 Ventures, MVP Ventures, Calibrate Ventures | ||||
 | Stem AI | Enterprise Software Data Intelligence | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $41.15MM | Series Seed-1 | 12/19/2024 | $25MM | $540.31MM | $28.84 | Andreessen Horowitz | ||||
 | Metromile | Fintech Insurance | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $286.98MM | Series E | 8/1/2018 | $90MM | $540.2MM | $6.39 | Intact Ventures, Tokio Marine Holdings, Index Ventures (UK), New Enterprise Associates, Section 32, Australia Future Fund | ||||
 | Bambusa Therapeutics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $142.98MM | Series A-2 | 11/17/2025 | $40MM | $539.54MM | $18.73 | Athos KG, RA Capital Management, INCE Capital, Redmile Group, BVF Partners, Salvia, Janus Henderson Investors, Invus, ADAR1 Capital Management, Dawn Biopharma | ||||
 | Dyno Therapeutics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $111MM | Series A | 5/6/2021 | $100MM | $539.27MM | $44.66 | Andreessen Horowitz, Casdin Capital, GV, Obvious Ventures, Lux Capital | ||||
 | Aryaka | Enterprise Software Cloud / Networking Infrastructure | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $202.51MM | Series F | 5/1/2019 | $65MM | $538.61MM | $2.72 | Goldman Sachs Private Capital Investing, Trinity Ventures, Mohr Davidow Ventures, Nexus Venture Partners, InterWest Partners, Presidio Ventures, Third Point Ventures, DTCP | ||||